Efficacy News and Research

RSS
FDA approves GSK’s raxibacumab to treat inhalational anthrax

FDA approves GSK’s raxibacumab to treat inhalational anthrax

GSK receives FDA approval for raxibacumab to treat inhalational anthrax

GSK receives FDA approval for raxibacumab to treat inhalational anthrax

Graphic images best anti-smoking message

Graphic images best anti-smoking message

Pairing statins with cyclin-dependent kinase inhibitors might effectively treat melanomas

Pairing statins with cyclin-dependent kinase inhibitors might effectively treat melanomas

Pfizer, Ligand announce FDA acceptance of bazedoxifene/conjugated estrogens NDA

Pfizer, Ligand announce FDA acceptance of bazedoxifene/conjugated estrogens NDA

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Unigene announces results from oral PTH Phase 2 study on osteoporosis

Unigene announces results from oral PTH Phase 2 study on osteoporosis

Industry sponsored clinical trials present a more favourable picture of reported findings

Industry sponsored clinical trials present a more favourable picture of reported findings

Depression treatment ‘should target emotional control’

Depression treatment ‘should target emotional control’

Depression treatment ‘should target emotional control’

Depression treatment ‘should target emotional control’

Astellas, Ambit announce results from quizartinib Phase 2 study on acute myeloid leukemia

Astellas, Ambit announce results from quizartinib Phase 2 study on acute myeloid leukemia

Studies examine current treatment standards for patients with clotting disorders

Studies examine current treatment standards for patients with clotting disorders

Pomalidomide safe and effective in treating multiple myeloma

Pomalidomide safe and effective in treating multiple myeloma

Study finds high serum galectin-1 levels in Hodgkin lymphoma patients

Study finds high serum galectin-1 levels in Hodgkin lymphoma patients

Janssen announces U.S. prescribing information update for EDURANT tablets

Janssen announces U.S. prescribing information update for EDURANT tablets

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

Ligand commences PG-free melphalan pivotal trial in multiple myeloma

Ligand commences PG-free melphalan pivotal trial in multiple myeloma

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.